Evidence map›Paper›PMID 40747592›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Machine learning diagnosis of cognitive impairment and dementia in harmonized older adult cohorts.

Dan Mungas, Brandon Gavett, L Paloma Rojas-Saunero, Yixuan Zhou, Eleanor Hayes-Larson, Crystal Shaw, Sarah Tomaszewski Farias, Keith Widaman, Evan Fletcher, Maria M Corrada and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Machine learning diagnosis of cognitive impairment and dementia in harmonized older adult cohorts.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  2. Beyond black-box AI: Interpretable hybrid systems for dementia care.Alzheimer's & dementia (Amsterdam, Netherlands)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dan MungasDepartment of Neurology, UC Davis School of Medicine, Sacramento, California, USA.
Brandon GavettDepartment of Neurology, UC Davis School of Medicine, Sacramento, California, USA.
L Paloma Rojas-SauneroDepartment of Epidemiology, University of California Los Angeles Fielding School of Public Health, Los Angeles, California, USA.
Yixuan ZhouDepartment of Epidemiology, University of California Los Angeles Fielding School of Public Health, Los Angeles, California, USA.
Eleanor Hayes-LarsonLeonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
Crystal ShawOncology Department, Amgen, Inc., Thousand Oaks, California, USA.
Sarah Tomaszewski FariasDepartment of Neurology, UC Davis School of Medicine, Sacramento, California, USA.
Keith WidamanSchool of Education and Graduate Division, University of California Riverside, Riverside, California, USA.
Evan FletcherDepartment of Neurology, UC Davis School of Medicine, Sacramento, California, USA.
Maria M CorradaDepartment of Neurology, University of California Irvine School of Medicine, Orange, California, USA.
Paola GilsanzNorthern California Division of Research, Kaiser Permanente, Pleasanton, California, USA.
Maria GlymourDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
John OlichneyDepartment of Neurology, UC Davis School of Medicine, Sacramento, California, USA.
Charles DeCarliDepartment of Neurology, UC Davis School of Medicine, Sacramento, California, USA.
Rachel WhitmerDepartment of Neurology, UC Davis School of Medicine, Sacramento, California, USA.
Elizabeth Rose MayedaDepartment of Epidemiology, University of California Los Angeles Fielding School of Public Health, Los Angeles, California, USA.

Funding

Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in Cohort of Oldest-OldR01AG056519 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Maria Corrada, Paola Gilsanz · 2022 to 2026
$25.8M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI OANH L MEYER · 2021 to 2026
$25.2M
Lifecourse health, cerebral pathology and ethnic disparities in dementia (KHANDLE Study)R01AG052132 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GILSANZ, PAOLA, GLYMOUR, MEDELLENA MARIA · 2021 to 2025
$18.0M
Brain pathologies, reserve and cognition in aging and dementiaR01AG031563 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Evan Fletcher, SARAH E TOMASZEWSKI-FARIAS · 2009 to 2026
$8.9M
Effects of lifecourse traumatic stress on late-life cognitive decline, dementia, and neuroimaging biomarkersR00AG075317 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Eleanor Louise Hayes-Larson · 2024 to 2026
$742k
Effects of lifecourse traumatic stress on late-life cognitive decline, dementia, and neuroimaging biomarkersK99AG075317 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAYES-LARSON, ELEANOR LOUISE · 2022 to 2023
$241k
NIA NIH HHS K99 AG075317NIA NIH HHS K99AG075317NIA NIH HHS P30 AG072972NIA NIH HHS P30AG072972NIA NIH HHS R00 AG075317NIA NIH HHS R01 AG031563NIA NIH HHS R01AG031563NIA NIH HHS R01 AG052132NIA NIH HHS R01AG052132NIA NIH HHS R01 AG056519NIA NIH HHS R01AG056519
6 · The paper itself

Abstract

introductionClinical diagnosis (normal cognition, mild cognitive impairment [MCI], dementia) is critical for understanding cognitive impairment and dementia but can be resource intensive and subject to inconsistencies due to complex clinical judgments that are required. Machine learning approaches might provide meaningful additions and/or alternatives to traditional clinical diagnosis.

methodsThe study sample was composed of three harmonized longitudinal cohorts of demographically diverse older adults. We used the XGBoost extreme gradient boosting platform to predict clinical diagnosis using different feature sets.

resultsMeasures of cognition were especially important predictive features of clinical diagnosis. Prediction accuracy was higher in a sample that had longer follow-up, better balance across diagnostic outcomes, and both self- and informant-report independent function measures. DISCUSSION: Algorithmic diagnosis might be a meaningful substitute for clinical diagnosis in studies in which clinical evaluation and diagnosis are not feasible for all participants and may provide a standardized alternative when clinical diagnosis is available. HIGHLIGHTS: A machine learning algorithm was used to diagnose cognitive impairment and dementia. Measures of cognition were strongest predictive features for clinical diagnosis. Algorithm accuracy was improved by informant-report independent function measures. Algorithmic diagnosis might be an alternative if clinical diagnosis is not feasible. Standardization is an important advantage of algorithmic diagnosis.

Indexed as

Cognitive DysfunctionDementiaMachine LearningAgedAged, 80 and overAlgorithmsCohort StudiesFemaleHumansLongitudinal StudiesMaleNeuropsychological Testsalgorithmic diagnosisclinical assessmentcognitive impairmentdementia diagnosislongitudinal cohortsmachine learningmild cognitive impairmentneuropsychological measurespredictive modelingXGBoost algorithm

Identifiers

PMID40747592
PMCPMC12314546

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.